Dismiss Modal
Isabel L. Virella-Lowell, MD

Isabel L. Virella-Lowell, MD

Pulmonology and Sleep Medicine
Professor

Office Locations

Professor, Co-Director, UAN Therapeutics Development Network; Medical Director, Pediatric Pulmonary Care Unit, Titles: Professor Co-Director, CF Therapeutics Development Network Center Co-Director, Airways Clinical Research Center Co-Director Pediatric Pulmonary Clinical Research Program Medical Director of 10Q Pediatric Pulmonary Care Unit

Education

  • Residency: University of Florida
  • Medical School: Medical Univeristy of South Carolina
  • Internship: University of Florida
  • UnderGraduate: Duke University

Board Certifications

  • American Board of Pediatrics: Pediatrics (1970)
  • American Board of Pediatrics - Pediatric Pulmonology (1970)

Languages Spoken

Portuguese
Spanish

Honors and Awards

Best Doctors in America

Interests

asthma, cystic fibrosis, clinical trials, transition to adult care, quality improvement, patient safety

Professional Organizations

Society for Pediatric Research, American Academy of Pediatrics, American Thoracic Society

Publications

PUBLICATIONS: https://www.ncbi.nlm.nih.gov/pubmed/?term=virella-lowell%2C+i 1.Urte Sommerwerck, Isabel Virella-Lowell, Gerhild Angyalosi Andrea Viegas, Weihua Cao, Laurie Debonnett. Long-term Safety of Tobramycin Powder for Inhalation in Cystic Fibrosis Patients: Results from a Phase IV (ETOILES) Study. Curr Med Res Opin. 2016 Jul 20:1-2 2. S Morrow Buff, H Yu, J McCall, S Caldwell, T Ferkol, T Flotte, and I Virella-Lowell. IL-10 delivery by adeno-associated vector attenuates inflammation in mice with Pseudomonas pneumonia. Gene Ther. 2010 May;17(5):567-76. 3. H Yu, Y Zeidan, B Wu, T Flotte, Y Hannun, and I Virella-Lowell. Loss of induction of acid sphingomyelinase is associated with persistent pseudomonas aeruginosa infection in cystic fibrosis. Am J Respir Cell Mol Biol. (2009) Jan 23. 4. Jennifer L Wentzel, MS, Isabel Virella-Lowell, MD, Zachary M. Soler, MD, MSc. Quantitative sinonasal symptom assessment in an unselected pediatric population with cystic fibrosis. Am J Rhinol Allergy. 2015 Sep-Oct;29(5):357-61. 5. sabel Virella-Lowell, Amy Poirier, Kye A. Chesnut, Mark Brantly, and Terence R. Flotte. Inhibition of Recombinant Adeno-associated Virus (rAAV) Transduction by Bronchial Secretions From Cystic Fibrosis Patients. Gene Ther 2000. 7(20)1783-1789.